Table 1. Hiwi mRNA: clinical and histopathological data of ductal adenocarcinoma of the pancreas patients.

				Stage
Patient no.	Age at surgery	Sex	Survival (months)	T	N	M	R-status	Grading	Hiwi mRNA (in ag/fg HPRT)
1	59	M	13	3	1	0	0	2	28.241
2	53	F	16	3	1	0	0	2	0.038
3	60	F	21	3	0	0	0	2	1.366
4	64	M	Alivea	3	0	0	1	3	0.139
5	40	F	19	3	1	0	0	3	0.010
6	59	M	24	3	1	0	0	3	0.979
7	47	F	20	3	1	0	0	2	0.072
8	46	F	15	3	1	0	0	2	1.825
9	71	M	5	3	0	0	1	3	0.576
10	66	F	4	4	1	0	2	1	0.000
11	70	M	15	3	1	0	1	3	7.689
12	67	M	6	3	1	0	0	2	0.000
13	74	M	3	4	1	1	2	1	0.523
14	75	F	49	3	1	0	0	2	1.139
15	49	M	22	3	1	0	0	1	1.112
16	70	M	4	3	1	0	0	3	2.526
17	68	M	11	3	0	0	0	3	0.000
18	72	F	33	3	1	0	1	2	0.935
19	73	F	1	3	1	0	0	1	0.000
20	58	M	43	3	2	0	0	2	0.077
21	74	M	Alivea	3	1	0	0	3	0.003
22	69	F	15	4	2	1	2	3	0.060
23	43	M	2	3	2	1	2	3	0.000
24	56	M	5	4	2	1	2	2	0.069
25	48	M	9	2	1	0	0	3	0.000
26	70	M	8	4	2	1	2	2	0.141
27	76	M	15	3	0	0	0	2	0.063
28	57	F	3	4	0	0	0	3	0.053
29	61	M	14	2	1	0	0	3	0.030
30	69	M	9	3	1	0	0	2	0.545
31	47	M	2	3	1	0	0	3	5.160
32	52	F	29	3	0	0	0	2	0.000
33	38	F	4	4	2	1	2	1	0.112
34	65	M	16	3	0	0	0	3	0.074
35	75	M	13	3	0	0	0	2	0.010
36	60	F	4	3	1	1	1	3	0.015
37	61	F	37	3	1	0	0	2	0.005
38	62	F	16	3	0	0	1	2	0.000
39	80	M	33	3	1	0	0	1	0.000
40	69	F	1	3	1	0	0	2	0.027
41	42	M	3	4	2	1	2	3	0.050
42	52	M	Alivea	3	1	0	0	3	0.000
43	52	M	13	3	1	0	0	3	0.000
44	71	F	23	3	0	0	0	2	2.374
45	64	F	Alivea	1	1	0	0	2	0.000
46	69	M	Alivea	3	1	0	0	1	0.109
47	68	F	Alivea	2	0	0	0	2	0.203
48	34	M	6	3	1	0	1	3	0.000
49	61	F	12	2	0	0	0	3	0.114
50	71	M	12	3	0	0	0	2	0.000
51	66	M	17	3	1	0	0	2	2.920
52	71	F	11	3	1	0	2	3	3.213
53	67	M	17	3	1	0	0	3	0.182
54	67	M	6	3	1	0	1	3	0.000
55	69	M	5	3	1	1	2	2	0.000
56	55	M	8	3	1	0	1	3	0.016

^aAt follow-up.